| Dr Sharon Gabriel, DDS | |
|
320 N Verdugo Rd, Ste 100, Glendale, CA 91206-5238 | |
| (818) 548-0608 | |
| (818) 548-0648 |
| Full Name | Dr Sharon Gabriel |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 320 N Verdugo Rd, Glendale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255426821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 43338 (California) | Primary |
| 122300000X | Dentist | DT-1929 (Hawaii) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sharon Gabriel, DDS 320 N Verdugo Rd, Ste 100, Glendale, CA 91206-5238 Ph: (818) 548-0608 | Dr Sharon Gabriel, DDS 320 N Verdugo Rd, Ste 100, Glendale, CA 91206-5238 Ph: (818) 548-0608 |
News Archive
Researchers at the University of Michigan are interested in changing the behavior of some 2 million farm youths affected by hazardous noise exposure and hearing loss in the United States.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today it has signed a distribution agreement with Cipher Pharmaceuticals Inc. to distribute Can-Fite's lead drug candidate, CF101, for the treatment of moderate to severe psoriasis and rheumatoid arthritis in the Canadian market upon receipt of regulatory approvals.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Merck, known as MSD outside the United States and Canada, today announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00 per share in cash without interest and less any applicable withholding taxes.
DePuy Synthes CMF today announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery. DePuy Synthes CMF is a part of the DePuy Synthes Companies of Johnson & Johnson.
› Verified 5 days ago
Dr. Alenush D Bernardi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1110 N Brand Blvd Ste 201, Glendale, CA 91202 Phone: 818-244-0215 | |
Dr. Lyla A. Gazarian-boustani, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 230 N Maryland Ave, Suite 206, Glendale, CA 91206 Phone: 818-547-2804 | |
Maricel Guarin Fortin, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1415 E Colorado St, Ste C, Glendale, CA 91205 Phone: 818-545-7270 | |
Dr. Lloyd Thomas Turner, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1111 N Brand Blvd, Suite B, Glendale, CA 91202 Phone: 818-246-5611 | |
Alexander Lalabekyan, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 457 W Colorado St, Suite#201, Glendale, CA 91204 Phone: 818-543-0707 Fax: 818-543-0700 | |
Andre Eliasian, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1249 W Glenoaks Blvd, Glendale, CA 91201 Phone: 818-649-1772 Fax: 818-649-1774 | |
Dr. Greg Tashdjian, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 316 E Broadway, Glendale, CA 91205 Phone: 818-548-7700 |